公司新闻 - 亚科因（Abbkine）—服务于细胞和蛋白研究全球用户

首页
技术中心
产品文献

或

货号	产品名称	文献标题	IF	杂志名称
BMU102	SuperKine™ 超敏型ECL发光液（飞克级）	Fasudil attenuates oxidative stress-induced partial epithelial-mesenchymal transition of tubular epithelial cells in hyperuricemic nephropathy via activating Nrf2.	4	European Journal of Pharmacology
BMU102	SuperKine™ 超敏型ECL发光液（飞克级）	CAG peptide functionalized graphene quantum dots-cationic polymer composite gene carriers.	11	Journal of Materials Chemistry
BMU102	SuperKine™ 超敏型ECL发光液（飞克级）	The CoV-Y domain of SARS-CoV-2 Nsp3 interacts with BRAP to stimulate NF-κB signaling and induce host inflammatory responses.	8	International Journal of Biological Macromolecules
BMU102	SuperKine™ 超敏型ECL发光液（飞克级）	High expression of malic enzyme 1 predicts adverse prognosis in patients with cytogenetically normal acute myeloid leukaemia and promotes leukaemogenesis through the IL-6/JAK2/STAT3 pathways.	3	Therapeutic Advances in Hematology
BMU102	SuperKine™ 超敏型ECL发光液（飞克级）	Molecular basis for loss of virulence in Magnaporthe oryzae strain AM16.	4	Frontiers in Plant Science
BMU102	SuperKine™ 超敏型ECL发光液（飞克级）	CX‑5461 potentiates imatinib‑induced apoptosis in K562 cells by stimulating KIF1B expression.	2	Experimental and Therapeutic Medicine
BMU102	SuperKine™ 超敏型ECL发光液（飞克级）	An oncolytic virus–T cell chimera for cancer immunotherapy.	33	Nature Biotechnology
BMU102	SuperKine™ 超敏型ECL发光液（飞克级）	Bioinformatics analysis and experimental verification of NLRX1 as a prognostic factor for esophageal squamous cell carcinoma.	2	Oncology Letters
BMU102	SuperKine™ 超敏型ECL发光液（飞克级）	HIF-1α affects invasion and metastasis of prostate cancer by regulating invadopodia formation.
BMU102	SuperKine™ 超敏型ECL发光液（飞克级）	Jolkinolide B ameliorates rheumatoid arthritis by regulating the JAK2/STAT3 signaling pathway.	7	Phytomedicine

首页上一页 320 321 322 323 324 325 下一页尾页

赋能细胞研究与治疗 Enabling cell research and therapy

联系我们

全国服务热线： 400-6800-830

订购邮箱： service@abbkine.com

联系地址：武汉光谷生物医药加速器17号楼1号房2-3层

友情链接：

Copyright ©Abbkine Scientific Co., Ltd- 鄂ICP备10204150号-5

意见反馈

 在线咨询

扫码关注

微信公众号

返回顶部